Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1BT----3件: 96, 97, 98 💬
2BT-11----2件: 96, 97 💬
3BT-11 (1000 mg)----1件: 97 💬
4BT-11 (500 mg)----1件: 97 💬
5BT-11 (Omilancor)----1件: 96 💬
6BT-11 1,000 mg----1件: 96 💬
7BT-11 1000mg----3件: 96, 97, 98 💬
8BT-11 500 mg----2件: 96, 97 💬
9BT-11 500mg----1件: 98 💬
10BT-11 Active----2件: 96, 97 💬
11BT051 200 mg----1件: 97 💬
12BT051 3200 mg----1件: 97 💬
13BT051 800 mg----1件: 97 💬
14BT061----1件: 46 💬
15BT061 (CD4 monoclonal antibody)----1件: 46 💬
16BT063----1件: 49 💬
17BT090----1件: 65 💬
18BT524----1件: 65 💬
19BT595----2件: 63, 65 💬
20BT681----1件: 65 💬
21BT971----1件: 46 💬
22BTK Inhibitor----3件: 46, 53, 160 💬
23BTRX-2460401件: BTRX-246040---1件: 6 💬
24BTT-1023----1件: 46 💬
25BTT1023----1件: 94 💬
26BTT1023 IV Infusion 20 mg/mL, 5 mL Drug Product----1件: 94 💬
27BTX-A1件: Botulinum toxin type A (BTX-A)1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
28Bupivacaine, triamcinolone, and heparin (BTH)3件: Bupivacaine,
Heparin,
Triamcinolone
3件: Triamcinolone ,
Adomiparin ,
Bupivacaine 💬
7件: NR3C1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬
5件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction 💬1件: 226 💬
29Dysport® (Botulinumtoxin A (Btx A))1件: Botulinum toxin type A (BTX-A)1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 36 💬
30IgG Next Generation (BT595)----1件: 65 💬
31Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología PRGF-System (BTI)----1件: 96 💬